Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
3.
Int J Antimicrob Agents ; 52(3): 385-389, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29906564

ABSTRACT

BACKGROUND: Extensively-drug-resistant bacteria (XDRB) have emerged as a major source of resistance. Hospitalization abroad seems to be the major risk factor associated with carriage, and numerous reports have warned about the risk of in-hospital transmission. However, little is known regarding possible community transmission. METHODS: A retrospective matched case-control study was conducted in a Parisian teaching hospital, which included patients admitted to hospital with a history of travel abroad over the preceding 12 months. Each XDRB carrier at admission (case) was matched with two non-carriers (controls) hospitalized in the same ward and admitted during the same month. AIM: To describe and identify risk factors associated with XDRB carriage at admission. FINDINGS: Forty-six cases and 92 controls were enrolled. The results of univariate and multi-variate analyses showed that health repatriation was the only factor associated with a higher risk of carrying XDRB (odds ratio 3.22, 95% confidence interval 1.23-7.84; P=0.01). Surprisingly, one-third of the study population had not been hospitalized abroad within the preceding 12 months. The most frequently identified XDRB species were Escherichia coli (36%), Enterococcus spp. (17%) and Klebsiella pneumoniae (9%), and the most frequently identified enzyme was OXA-48 (36%). CONCLUSION: In this retrospective study, health repatriation was the only risk factor for XDRB carriage identified at admission. Furthermore, the data suggest community-onset transmission. Therefore, there is an urgent need to conduct studies in high-risk countries to identify the risk factors associated with community carriage.


Subject(s)
Carbapenem-Resistant Enterobacteriaceae/isolation & purification , Communicable Diseases, Imported/epidemiology , Communicable Diseases, Imported/transmission , Enterobacteriaceae Infections/epidemiology , Enterobacteriaceae Infections/transmission , Gram-Positive Bacterial Infections/epidemiology , Gram-Positive Bacterial Infections/transmission , Vancomycin-Resistant Enterococci/isolation & purification , Carbapenem-Resistant Enterobacteriaceae/drug effects , Case-Control Studies , Communicable Diseases, Imported/therapy , Drug Resistance, Multiple, Bacterial , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae Infections/therapy , Escherichia coli/drug effects , Escherichia coli/genetics , Escherichia coli Proteins/genetics , Female , Gram-Positive Bacterial Infections/microbiology , Gram-Positive Bacterial Infections/therapy , Hospitalization/statistics & numerical data , Humans , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/genetics , Male , Middle Aged , Retrospective Studies , Travel , Vancomycin-Resistant Enterococci/drug effects , beta-Lactamases/genetics
SELECTION OF CITATIONS
SEARCH DETAIL